SCHEMBL6174447

SCHEMBL6174447

CC1(Cc2ccncc2NNC(=O)c2ccccc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
GAA P10253 2/20 0.42
TRPV1 Q8NER1 3/20 0.37
TLR7 Q9NYK1 2/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
NAMPT P43490 1/20 0.35
HSD17B13 Q7Z5P4 1/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
CYP1A2 P05177 1/20 0.35
F2R P25116 1/20 0.35
SCN2A Q99250 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
GSK3A P49840 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174087 0.87 IGF1R (0.40) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL6176657 0.85 CYP3A4 (0.40) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL6174981 0.85 CYP3A4 (0.51) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL6277096 0.85 CYP3A4 (0.43) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL6175827 0.85 NPC1 (0.46) TRPV1NAMPT
SCHEMBL6175943 0.84 ALDH1A1 (0.43) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL6171757 0.84 CYP3A4 (0.41) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL6708303 0.84 TRPV1 (0.50) ALDH1A1TRPV1NAMPTKDM5AKDM4C
SCHEMBL6173183 0.84 CYP3A4 (0.39) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL6175149 0.83 ALDH1A1 (0.42) ALDH1A1CYP3A4CYP2C9CYP2C19GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed